Reactive oxygen species, Nox and angiotensin II in angiogenesis: Implications for retinopathy

Clinical Science

Volumn 124, Issue 10, 2013, Pages 597-615

  Wilkinson Berka, Jennifer L ^a,b   Rana, Indrajeetsinh ^a,b   Armani, Roksana ^a,b   Agrotis, Alex ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b The Alfred Centre   (Australia)

Author keywords

Aldosterone; Diabetic retinopathy; NADPH oxidase; Oxidative stress; Renin angiotensin aldosterone system (RAAS); retinopathy of prematurity

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; BEVACIZUMAB; CYTOCHROME P450; HYPOXIA INDUCIBLE FACTOR 1; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 3; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 5; UNCLASSIFIED DRUG; VASCULOTROPIN INHIBITOR; XANTHINE OXIDASE;

ANGIOGENESIS; CARDIOVASCULAR DISEASE; DIABETIC RETINOPATHY; HUMAN; HYPERTENSION; HYPOXIA; INCIDENCE; INFLAMMATION; LASER COAGULATION; MITOCHONDRIAL ENERGY TRANSFER; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RETINA; RETROLENTAL FIBROPLASIA; REVIEW;

ANGIOTENSIN II; ANIMALS; DIABETIC RETINOPATHY; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INFANT, NEWBORN; INFANT, PREMATURE; INFLAMMATION; MEMBRANE GLYCOPROTEINS; MODELS, ANIMAL; NADPH OXIDASE; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RENIN-ANGIOTENSIN SYSTEM; RETINA; RETINOPATHY OF PREMATURITY;

EID: 84874720620     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20120212     Document Type: Review

References (282)

1. Alon, T., Hemo, I., Itin, A., Pe'er, J., Stone, J. and Keshet, E. (1995) Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat. Med. 1, 1024-1028
2. Robinson, G. S., Pierce, E. A., Rook, S. L., Foley, E., Webb, R. and Smith, L. E. (1996) Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. Proc. Natl. Acad. Sci. U.S.A. 93, 4851-4856
3. Pierce, E. A., Foley, E. D. and Smith, L. E. (1996) Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch. Ophthalmol. 114, 1219-1228
4. Oliner, J. D., Bready, J., Nguyen, L., Estrada, J., Hurh, E., Ma, H., Pretorius, J., Fanslow, W., Nork, T. M., Leedle, R. A. et al. (2012) AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, inhibits angiogenesis in models of ocular neovascular diseases. Invest. Ophthalmol. Visual Sci. 53, 2170-2180
5. Joussen, A. M., Poulaki, V., Tsujikawa, A., Qin, W., Qaum, T., Xu, Q., Moromizato, Y., Bursell, S. E., Wiegand, S. J., Rudge, J. et al. (2002) Suppression of diabetic retinopathy with angiopoietin-1. Am. J. Pathol. 160, 1683-1693
6. Hammes, H. P., Lin, J., Wagner, P., Feng, Y., Vom Hagen, F., Krzizok, T., Renner, O., Breier, G., Brownlee, M. and Deutsch, U. (2004) Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy. Diabetes 53, 1104-1110
7. Cai, J., Kehoe, O., Smith, G. M., Hykin, P. and Boulton, M. E. (2008) The angiopoietin/Tie-2 system regulates pericyte survival and recruitment in diabetic retinopathy. Invest. Ophthalmol. Visual Sci. 49, 2163-2171
8. Chen, J., Connor, K. M., Aderman, C. M., Willett, K. L., Aspegren, O. P. and Smith, L. E. (2009) Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy. Invest. Ophthalmol. Visual Sci. 50, 1329-1335
9. Xiong, S. Q., Xia, X. B., Xu, H. Z. and Jiang, J. (2009) Suppression of retinal neovascularization by small-interference RNA targeting erythropoietin. Ophthalmologica 223, 306-312
10. Hernandez, C. and Simo, R. (2011) Erythropoietin produced by the retina: its role in physiology and diabetic retinopathy. Endocrine 41, 220-226
11. McVicar, C. M., Hamilton, R., Colhoun, L. M., Gardiner, T. A., Brines, M., Cerami, A. and Stitt, A. W. (2011) Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy. Diabetes 60, 2995-3005
12. Lima e Silva, R., Shen, J., Hackett, S. F., Kachi, S., Akiyama, H., Kiuchi, K., Yokoi, K., Hatara, M. C., Lauer, T., Aslam, S. et al. (2007) The SDF-1/CXCR4ligand/receptor pair is an important contributor to several types of ocular neovascularization. FASEB J. 21, 3219-3230
13. Sonmez, K., Drenser, K. A., Capone, Jr, A. and Trese, M. T. (2008) Vitreous levels of stromal cell-derived factor 1 and vascular endothelial growth factor in patients with retinopathy of prematurity. Ophthalmology 115, 1065-1070 e1061
14. Wilkinson-Berka, J. L., Agrotis, A. and Deliyanti, D. (2012) The retinal renin-angiotensin system: roles of angiotensin II and aldosterone. Peptides 36, 142-150
15. Moravski, C. J., Kelly, D. J., Cooper, M. E., Gilbert, R. E., Bertram, J. F., Shahinfar, S., Skinner, S. L. and Wilkinson-Berka, J. L. (2000) Retinal neovascularization is prevented by blockade of the renin-angiotensin system. Hypertension 36, 1099-1104
16. Deliyanti, D., Miller, A. G., Tan, G., Binger, K. J., Samson, A. L. and Wilkinson-Berka, J. L. (2012) Neovascularization is attenuated with aldosterone synthase inhibition in rats with retinopathy. Hypertension 59, 607-613
17. Wilkinson-Berka, J. L., Tan, G., Jaworski, K. and Ninkovic, S. (2007) Valsartan but not atenolol improves vascular pathology in diabetic Ren-2 rat retina. Am. J. Hypertens. 20, 423-430
18. Miller, A. G., Tan, G., Binger, K. J., Pickering, R. J., Thomas, M. C., Nagaraj, R. H., Cooper, M. E. and Wilkinson-Berka, J. L. (2010) Candesartan attenuates diabetic retinal vascular pathology by restoring glyoxalase-I function. Diabetes 59, 3208-3215
19. Lee, J. and Dammann, O. (2011) Perinatal infection, inflammation and retinopathy of prematurity. Semin. Fetal Neonatal Med. 17, 26-29
20. Ishikawa, K., Yoshida, S., Nakao, S., Sassa, Y., Asato, R., Kohno, R., Arima, M., Kita, T., Yoshida, A., Ohuchida, K. and Ishibashi, T. (2011) Bone marrow-derived monocyte lineage cells recruited by MIP-1β promote physiological revascularization in mouse model of oxygen-induced retinopathy. Lab. Invest. 92, 91-101
21. Kataoka, K., Nishiguchi, K. M., Kaneko, H., van Rooijen, N., Kachi, S. and Terasaki, H. (2010) The roles of vitreal macrophages and circulating leukocytes in retinal neovascularization. Invest. Ophthalmol. Visual Sci. 52, 1431-1438
22. Ishida, S., Yamashiro, K., Usui, T., Kaji, Y., Ogura, Y., Hida, T., Honda, Y., Oguchi, Y. and Adamis, A. P. (2003) Leukocytes mediate retinal vascular remodeling during development and vaso-obliteration in disease. Nat. Med. 9, 781-788
23. Yoshida, S., Yoshida, A., Ishibashi, T., Elner, S. G. and Elner, V. M. (2003) Role of MCP-1 and MIP-1α in retinal neovascularization during postischemic inflammation in a mouse model of retinal neovascularization. J. Leukocyte Biol. 73, 137-144
24. Ilg, R. C., Davies, M. H. and Powers, M. R. (2005) Altered retinal neovascularization in TNF receptor-deficient mice. Curr. Eye Res. 30, 1003-1013
25. Kociok, N., Radetzky, S., Krohne, T. U., Gavranic, C. and Joussen, A. M. (2006) Pathological but not physiological retinal neovascularization is altered in TNF-Rp55-receptor-deficient mice. Invest. Ophthalmol. Visual Sci. 47, 5057-5065
26. Zhang, W., Liu, H., Rojas, M., Caldwell, R. W. and Caldwell, R. B. (2011) Anti-inflammatory therapy for diabetic retinopathy. Immunotherapy 3, 609-628
27. Joussen, A. M., Poulaki, V., Mitsiades, N., Cai, W. Y., Suzuma, I., Pak, J., Ju, S. T., Rook, S. L., Esser, P., Mitsiades, C. S. et al. (2003) Suppression of Fas-FasL-induced endothelial cell apoptosis prevents diabetic blood-retinal barrier breakdown in a model of streptozotocin-induced diabetes. FASEB J. 17, 76-78
28. Smith, L. E. (2005) IGF-1 and retinopathy of prematurity in the preterm infant. Biol. Neonate. 88, 237-244
29. Vanhaesebrouck, S., Daniels, H., Moons, L., Vanhole, C., Carmeliet, P. and De Zegher, F. (2009) Oxygen-induced retinopathy in mice: amplification by neonatal IGF-I deficit and attenuation by IGF-I administration. Pediatr. Res. 65, 307-310
30. Connor, K. M., SanGiovanni, J. P., Lofqvist, C., Aderman, C. M., Chen, J., Higuchi, A., Hong, S., Pravda, E. A., Majchrzak, S., Carper, D. et al. (2007) Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat. Med. 13, 868-873
31. Donnelly, R., Idris, I. and Forrester, J. V. (2004) Protein kinase C inhibition and diabetic retinopathy: a shot in the dark at translational research. Br. J. Ophthalmol. 88, 145-151
32. Aiello, L. P., Bursell, S. E., Clermont, A., Duh, E., Ishii, H., Takagi, C., Mori, F., Ciulla, T. A., Ways, K., Jirousek, M. et al. (1997) Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective β-isoform-selective inhibitor. Diabetes 46, 1473-1480
33. Sun, W., Oates, P. J., Coutcher, J. B., Gerhardinger, C. and Lorenzi, M. (2006) A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy. Diabetes 55, 2757-2762
34. Dagher, Z., Park, Y. S., Asnaghi, V., Hoehn, T., Gerhardinger, C. and Lorenzi, M. (2004) Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathy. Diabetes 53, 2404-2411
35. Hammes, H. P., Brownlee, M., Edelstein, D., Saleck, M., Martin, S. and Federlin, K. (1994) Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat. Diabetologia 37, 32-35
36. Gardiner, T. A., Anderson, H. R. and Stitt, A. W. (2003) Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes. J. Pathol. 201, 328-333
37. Curtis, T. M., Hamilton, R., Yong, P. H., McVicar, C. M., Berner, A., Pringle, R., Uchida, K., Nagai, R., Brockbank, S. and Stitt, A. W. (2010) Muller glial dysfunction during diabetic retinopathy in rats is linked to accumulation of advanced glycation end-products and advanced lipoxidation end-products. Diabetologia 54, 690-698
38. Solaini, G., Baracca, A., Lenaz, G. and Sgarbi, G. (2010) Hypoxia and mitochondrial oxidative metabolism. Biochim. Biophys. Acta 1797, 1171-1177
39. Galanis, A., Pappa, A., Giannakakis, A., Lanitis, E., Dangaj, D. and Sandaltzopoulos, R. (2008) Reactive oxygen species and HIF-1 signalling in cancer. Cancer Lett. 266, 12-20
40. Stevenson, L., Matesanz, N., Colhoun, L., Edgar, K., Devine, A., Gardiner, T. A. and McDonald, D. M. (2010) Reduced nitro-oxidative stress and neural cell death suggests a protective role for microglial cells in TNFα - /- mice in ischemic retinopathy. Invest. Ophthalmol. Visual Sci. 51, 3291-3299
41. Bartoli, M., Al-Shabrawey, M., Labazi, M., Behzadian, M. A., Istanboli, M., El-Remessy, A. B., Caldwell, R. W., Marcus, D. M. and Caldwell, R. B. (2009) HMG-CoA reductase inhibitors (statin) prevents retinal neovascularization in a model of oxygen-induced retinopathy. Invest. Ophthalmol. Visual Sci. 50, 4934-4940
42. El-Remessy, A. B., Al-Shabrawey, M., Platt, D. H., Bartoli, M., Behzadian, M. A., Ghaly, N., Tsai, N., Motamed, K. and Caldwell, R. B. (2007) Peroxynitrite mediates VEGF's angiogenic signal and function via a nitration-independent mechanism in endothelial cells. FASEB J. 21, 2528-2539
43. Okuno, Y., Nakamura-Ishizu, A., Otsu, K., Suda, T. and Kubota, Y. (2012) Pathological neoangiogenesis depends on oxidative stress regulation by ATM. Nat. Med., doi:10.1038/nm.2846
44. Kowluru, R. A. and Abbas, S. N. (2003) Diabetes-induced mitochondrial dysfunction in the retina. Invest. Ophthalmol. Visual Sci. 44, 5327-5334
45. Du, Y., Miller, C. M. and Kern, T. S. (2003) Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radical Biol. Med. 35, 1491-1499
46. Cui, Y., Xu, X., Bi, H., Zhu, Q., Wu, J., Xia, X., Qiushi, R. and Ho, P. C. (2006) Expression modification of uncoupling proteins and MnSOD in retinal endothelial cells and pericytes induced by high glucose: the role of reactive oxygen species in diabetic retinopathy. Exp. Eye Res. 83, 807-816
47. Ellis, E. A., Guberski, D. L., Somogyi-Mann, M. and Grant, M. B. (2000) Increased H2O2, vascular endothelial growth factor and receptors in the retina of the BBZ/Wor diabetic rat. Free Radical Biol. Med. 28, 91-101
48. Nielsen, J. C., Naash, M. I. and Anderson, R. E. (1988) The regional distribution of vitamins E and C in mature and premature human retinas. Invest. Ophthalmol. Visual Sci. 29, 22-26
49. Penn, J. S., Tolman, B. L. and Bullard, L. E. (1997) Effect of a water-soluble vitamin E analog, trolox C, on retinal vascular development in an animal model of retinopathy of prematurity. Free Radical Biol. Med. 22, 977-984
50. Kowluru, R. A., Kanwar, M., Chan, P. S. and Zhang, J. P. (2008) Inhibition of retinopathy and retinal metabolic abnormalities in diabetic rats with AREDS-based micronutrients. Arch. Ophthalmol. 126, 1266-1272
51. Kowluru, R. A., Tang, J. and Kern, T. S. (2001) Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes 50, 1938-1942
52. Raju, T. N., Langenberg, P., Bhutani, V. and Quinn, G. E. (1997) Vitamin E prophylaxis to reduce retinopathy of prematurity: a reappraisal of published trials. J. Pediatr. 131, 844-850
53. Johnson, L., Quinn, G. E., Abbasi, S., Otis, C., Goldstein, D., Sacks, L., Porat, R., Fong, E., Delivoria-Papadopoulos, M., Peckham, G. et al. (1989) Effect of sustained pharmacologic vitamin E levels on incidence and severity of retinopathy of prematurity: a controlled clinical trial. J. Pediatr. 114, 827-838
54. Millen, A. E., Klein, R., Folsom, A. R., Stevens, J., Palta, M. and Mares, J. A. (2004) Relation between intake of vitamins C and E and risk of diabetic retinopathy in the Atherosclerosis Risk in Communities Study. Am. J. Clin. Nutr. 79, 865-873
55. Lee, C. T., Gayton, E. L., Beulens, J. W., Flanagan, D. W. and Adler, A. I. (2011) Micronutrients and diabetic retinopathy a systematic review. Ophthalmology 117, 71-78
56. Kobayashi, S., Nojima, Y., Shibuya, M. and Maru, Y. (2004) Nox1 regulates apoptosis and potentially stimulates branching morphogenesis in sinusoidal endothelial cells. Exp. Cell Res. 300, 455-462
57. Komatsu, D., Kato, M., Nakayama, J., Miyagawa, S. and Kamata, T. (2008) NADPH oxidase 1 plays a critical mediating role in oncogenic Ras-induced vascular endothelial growth factor expression. Oncogene 27, 4724-4732
58. Peshavariya, H., Dusting, G. J., Jiang, F., Halmos, L. R., Sobey, C. G., Drummond, G. R. and Selemidis, S. (2009) NADPH oxidase isoform selective regulation of endothelial cell proliferation and survival. Naunyn Schmiedebergs Arch. Pharmacol. 380, 193-204
59. Petry, A., Djordjevic, T., Weitnauer, M., Kietzmann, T., Hess, J. and Gorlach, A. (2006) NOX2 and NOX4 mediate proliferative response in endothelial cells. Antioxid. Redox Signaling 8, 1473-1484
60. Datla, S. R., Peshavariya, H., Dusting, G. J., Mahadev, K., Goldstein, B. J. and Jiang, F. (2007) Important role of Nox4 type NADPH oxidase in angiogenic responses in human microvascular endothelial cells in vitro. Arterioscler. Thromb. Vasc. Biol. 27, 2319-2324
61. Craige, S. M., Chen, K., Pei, Y., Li, C., Huang, X., Chen, C., Shibata, R., Sato, K., Walsh, K. and Keaney, Jr, J. F. (2011) NADPH oxidase 4 promotes endothelial angiogenesis through endothelial nitric oxide synthase activation. Circulation 124, 731-740
62. Garrido-Urbani, S., Jemelin, S., Deffert, C., Carnesecchi, S., Basset, O., Szyndralewiez, C., Heitz, F., Page, P., Montet, X., Michalik, L. et al. (2011) Targeting vascular NADPH oxidase 1 blocks tumor angiogenesis through a PPARα mediated mechanism. PLoS ONE 6, e14665
63. Arbiser, J. L., Petros, J., Klafter, R., Govindajaran, B., McLaughlin, E. R., Brown, L. F., Cohen, C., Moses, M., Kilroy, S., Arnold, R. S. and Lambeth, J. D. (2002) Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proc. Natl. Acad. Sci. U.S.A. 99, 715-720
64. Tojo, T., Ushio-Fukai, M., Yamaoka-Tojo, M., Ikeda, S., Patrushev, N. and Alexander, R. W. (2005) Role of gp91phox (Nox2)-containing NAD(P)H oxidase in angiogenesis in response to hindlimb ischemia. Circulation 111, 2347-2355
65. Ushio-Fukai, M., Tang, Y., Fukai, T., Dikalov, S. I., Ma, Y., Fujimoto, M., Quinn, M. T., Pagano, P. J., Johnson, C. and Alexander, R. W. (2002) Novel role of gp91phox-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ. Res. 91, 1160-1167
66. Schroder, K., Zhang, M., Benkhoff, S., Mieth, A., Pliquett, R., Kosowski, J., Kruse, C., Ludike, P., Michaelis, U. R., Weissmann, N. et al. (2012) Nox4 is a protective reactive oxygen species generating vascular NADPH Oxidase. Circ. Res. 109, 1217-1225
67. Griendling, K. K., Minieri, C. A., Ollerenshaw, J. D. and Alexander, R. W. (1994) Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 74, 1141-1148
68. Virdis, A., Neves, M. F., Amiri, F., Touyz, R. M. and Schiffrin, E. L. (2004) Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice. J. Hypertens. 22, 535-542
69. Yogi, A., Mercure, C., Touyz, J., Callera, G. E., Montezano, A. C., Aranha, A. B., Tostes, R. C., Reudelhuber, T. and Touyz, R. M. (2008) Renal redox-sensitive signaling, but not blood pressure, is attenuated by Nox1 knockout in angiotensin II-dependent chronic hypertension. Hypertension 51, 500-506
70. Valente, A. J., Clark, R. A., Siddesha, J. M., Siebenlist, U. and Chandrasekar, B. (2012) CIKS (Act1 or TRAF3IP2) mediates angiotensin-II-induced interleukin-18 expression and Nox2-dependent cardiomyocyte hypertrophy. J. Mol. Cell. Cardiol. 53, 113-124
71. Fazeli, G., Stopper, H., Schinzel, R., Ni, C. W., Jo, H. and Schupp, N. (2012) Angiotensin II induces DNA damage via AT1 receptor and NADPH oxidase isoform Nox4. Mutagenesis 27, 673-681
72. Cui, X. L., Chang, B. and Myatt, L. (2010) Expression and distribution of NADPH oxidase isoforms in human myometrium - role in angiotensin II-induced hypertrophy. Biol. Reprod. 82, 305-312
73. Ashton, N., Ward, B. and Serpell, G. (1954) Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia. Br. J. Ophthalmol. 38, 397-432
74. Patz, A. (1969) Retrolental fibroplasia. Surv. Ophthalmol. 14, 1-29
75. Good, W. V. (2006) The Early Treatment for Retinopathy Of Prematurity Study: structural findings at age 2 years. Br. J. Ophthalmol. 90, 1378-1382
76. Gibson, D. L., Sheps, S. B., Uh, S. H., Schechter, M. T. and McCormick, A. Q. (1990) Retinopathy of prematurity-induced blindness: birth weight-specific survival and the new epidemic. Pediatrics 86, 405-412
77. Hartnett, M. E., Gilbert, M. M., Hirose, T., Richardson, T. M. and Katsumi, O. (1993) Glaucoma as a cause of poor vision in severe retinopathy of prematurity. Graefes Arch. Clin. Exp. Ophthalmol. 231, 433-438
78. Choi, M. Y., Park, I. K. and Yu, Y. S. (2000) Long term refractive outcome in eyes of preterm infants with and without retinopathy of prematurity: comparison of keratometric value, axial length, anterior chamber depth and lens thickness. Br. J. Ophthalmol. 84, 138-143
79. Carden, S. M., Lan, L. N. and Huynh, T. (2006) Zone 1 retinopathy of prematurity in a transitional economy: a cautionary note. Am. J. Ophthalmol. 141, 1128-1129
80. World Health Organization (2007) Global initative fot the elimination of avoidable blindness: action plan 2006-2011, World Health Organization, Geneva
81. Provis, J. M., Leech, J., Diaz, C. M., Penfold, P. L., Stone, J. and Keshet, E. (1997) Development of the human retinal vasculature: cellular relations and VEGF expression. Exp. Eye Res. 65, 555-568
82. Stone, J., Itin, A., Alon, T., Pe'er, J., Gnessin, H., Chan-Ling, T. and Keshet, E. (1995) Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J. Neurosci. 15, 4738-4747
83. McLeod, D. S., Brownstein, R. and Lutty, G. A. (1996) Vaso-obliteration in the canine model of oxygen-induced retinopathy. Invest. Ophthalmol. Visual Sci. 37, 300-311
84. McLeod, D. S., Crone, S. N. and Lutty, G. A. (1996) Vasoproliferation in the neonatal dog model of oxygen-induced retinopathy. Invest. Ophthalmol. Visual Sci. 37, 1322-1333
85. Young, T. L., Anthony, D. C., Pierce, E., Foley, E. and Smith, L. E. (1997) Histopathology and vascular endothelial growth factor in untreated and diode laser-treated retinopathy of prematurity. J. AAPOS 1, 105-110
86. Hartnett, M. E. (2010) Studies on the pathogenesis of avascular retina and neovascularization into the vitreous in peripheral severe retinopathy of prematurity (an american ophthalmological society thesis). Trans. Am. Ophthalmol. Soc. 108, 96-119
87. International Committee for the Classification of Retinopathy of Prematurity (2005) The International Classification of Retinopathy of Prematurity revisited. Arch. Ophthalmol. 123, 991-999
88. Penn, J. S. and Thum, L. A. (1989) The rat as an animal model for retinopathy of prematurity. Prog. Clin. Biol. Res. 314, 623-642
89. Barnett, J. M., Yanni, S. E. and Penn, J. S. (2009) The development of the rat model of retinopathy of prematurity. Doc. Ophthalmol. 120, 3-12
90. Stone, J., Chan-Ling, T., Pe'er, J., Itin, A., Gnessin, H. and Keshet, E. (1996) Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity. Invest. Ophthalmol. Visual Sci. 37, 290-299
91. Nakamura-Ishizu, A., Kurihara, T., Okuno, Y., Ozawa, Y., Kishi, K., Goda, N., Tsubota, K., Okano, H., Suda, T. and Kubota, Y. (2012) The formation of an angiogenic astrocyte template is regulated by the neuroretina in a HIF-1-dependent manner. Dev. Biol. 363, 106-114
92. Bai, Y., Ma, J. X., Guo, J., Wang, J., Zhu, M., Chen, Y. and Le, Y. Z. (2009) Muller cell-derived VEGF is a significant contributor to retinal neovascularization. J. Pathol. 219, 446-454
93. Dorey, C. K., Aouididi, S., Reynaud, X., Dvorak, H. F. and Brown, L. F. (1996) Correlation of vascular permeability factor/vascular endothelial growth factor with extraretinal neovascularization in the rat. Arch. Ophthalmol. 114, 1210-1217
94. Donahue, M. L., Phelps, D. L., Watkins, R. H., LoMonaco, M. B. and Horowitz, S. (1996) Retinal vascular endothelial growth factor (VEGF) mRNA expression is altered in relation to neovascularization in oxygen induced retinopathy. Curr. Eye Res. 15, 175-184
95. Joussen, A. M., Doehmen, S., Le, M. L., Koizumi, K., Radetzky, S., Krohne, T. U., Poulaki, V., Semkova, I. and Kociok, N. (2009) TNF-α mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations. Mol. Vision 15, 1418-1428
96. Ritter, M. R., Banin, E., Moreno, S. K., Aguilar, E., Dorrell, M. I. and Friedlander, M. (2006) Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathy. J. Clin. Invest. 116, 3266-3276
97. Checchin, D., Sennlaub, F., Levavasseur, E., Leduc, M. and Chemtob, S. (2006) Potential role of microglia in retinal blood vessel formation. Invest. Ophthalmol. Visual Sci. 47, 3595-3602
98. Sola, A., Saldeno, Y. P. and Favareto, V. (2008) Clinical practices in neonatal oxygenation: where have we failed What can we do J. Perinatol. 28 (Suppl. 1), S28-S34
99. Mintz-Hittner, H. A. and Best, L. M. (2009) Antivascular endothelial growth factor for retinopathy of prematurity. Curr. Opin. Pediatr. 21, 182-187
100. Brar, V. S., Sharma, R. K., Murthy, R. K. and Chalam, K. V. (2010) Bevacizumab neutralizes the protective effect of vascular endothelial growth factor on retinal ganglion cells. Mol. Vision 16, 1848-1853
101. Darlow, B. A., Gilbert, C., Quinn, G. E., Azad, R., Ells, A. L., Fielder, A. and Zin, A. (2009) Promise and potential pitfalls of anti-VEGF drugs in retinopathy of prematurity. Br. J. Ophthalmol. 93, 986
102. Wang, Y., Jin, K., Mao, X. O., Xie, L., Banwait, S., Marti, H. H. and Greenberg, D. A. (2007) VEGF-overexpressing transgenic mice show enhanced post-ischemic neurogenesis and neuromigration. J. Neurosci. Res. 85, 740-747
103. Wilkinson, C. P., Ferris, III, F. L., Klein, R. E., Lee, P. P., Agardh, C. D., Davis, M., Dills, D., Kampik, A., Pararajasegaram, R. and Verdaguer, J. T. (2003) Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110, 1677-1682
104. Fletcher, E. L., Phipps, J. A., Ward, M. M., Puthussery, T. and Wilkinson-Berka, J. L. (2007) Neuronal and glial cell abnormality as predictors of progression of diabetic retinopathy. Curr. Pharm. Des. 13, 2699-2712
105. Pe'er, J., Folberg, R., Itin, A., Gnessin, H., Hemo, I. and Keshet, E. (1996) Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy. Br. J. Ophthalmol. 80, 241-245
106. Gerhardinger, C., Brown, L. F., Roy, S., Mizutani, M., Zucker, C. L. and Lorenzi, M. (1998) Expression of vascular endothelial growth factor in the human retina and in nonproliferative diabetic retinopathy. Am. J. Pathol. 152, 1453-1462
107. Takagi, H., King, G. L. and Aiello, L. P. (1996) Identification and characterization of vascular endothelial growth factor receptor (Flt) in bovine retinal pericytes. Diabetes 45, 1016-1023
108. Tang, J. and Kern, T. S. (2011) Inflammation in diabetic retinopathy. Prog. Retin. Eye Res. 30, 343-358
109. Yau, J. W., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., Chen, S. J., Dekker, J. M., Fletcher, A., Grauslund, J. et al. (2012) Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35, 556-564
110. Diabetes Control and Complications Trial/Epidemiology of Diabets Interventions and Complications Research Group (2000) Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. Am. J. Ophthalmol. 129, 704-705
111. UK Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br. Med. J. 317, 703-713
112. Fong, D. S., Aiello, L., Gardner, T. W., King, G. L., Blankenship, G., Cavallerano, J. D., Ferris, III, F. L. and Klein, R. (2004) Retinopathy in diabetes. Diabetes Care 27 (Suppl. 1), S84-S87
113. Robinson, R., Barathi, V. A., Chaurasia, S. S., Wong, T. Y. and Kern, T. S. (2012) Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals. Dis. Model Mech. 5, 444-456
114. Glenn, J. V. and Stitt, A. W. (2009) The role of advanced glycation end products in retinal ageing and disease. Biochim. Biophys. Acta 1790, 1109-1116
115. Mohamed, Q., Gillies, M. C. and Wong, T. Y. (2007) Management of diabetic retinopathy: a systematic review. JAMA, J. Am. Med. Assoc. 298, 902-916
116. Pahor, D. (1998) Visual field loss after argon laser panretinal photocoagulation in diabetic retinopathy: full- versus mild-scatter coagulation. Int. Ophthalmol. 22, 313-319
117. Fong, D. S., Barton, F. B. and Bresnick, G. H. (1999) Impaired color vision associated with diabetic retinopathy: Early Treatment Diabetic Retinopathy Study Report No. 15. Am. J. Ophthalmol. 128, 612-617
118. Jeganathan, V. S. (2010) Anti-angiogenesis drugs in diabetic retinopathy. Curr. Pharm. Biotechnol. 12, 369-372
119. Schmidinger, G., Maar, N., Bolz, M., Scholda, C. and Schmidt-Erfurth, U. (2011) Repeated intravitreal bevacizumab (Avastin®) treatment of persistent new vessels in proliferative diabetic retinopathy after complete panretinal photocoagulation. Acta Ophthalmol. 89, 76-81
120. Sharma, S., Johnson, D., Abouammoh, M., Hollands, S. and Brissette, A. (2012) Rate of serious adverse effects in a series of bevacizumab and ranibizumab injections. Can. J. Ophthalmol. 47, 275-279
121. Roh, M. I., Kim, H. S., Song, J. H., Lim, J. B. and Kwon, O. W. (2009) Effect of intravitreal bevacizumab injection on aqueous humor cytokine levels in clinically significant macular edema. Ophthalmology 116, 80-86
122. Schippers, J. H., Nguyen, H. M., Lu, D., Schmidt, R. and Mueller-Roeber, B. (2012) ROS homeostasis during development: an evolutionary conserved strategy. Cell. Mol. Life Sci. 69, 3245-3257
123. Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H. P., Giardino, I. and Brownlee, M. (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404, 787-790
124. Ohno, Y. and Gallin, J. I. (1985) Diffusion of extracellular hydrogen peroxide into intracellular compartments of human neutrophils. Studies utilizing the inactivation of myeloperoxidase by hydrogen peroxide and azide. J. Biol. Chem. 260, 8438-8446
125. Weyemi, U. and Dupuy, C. (2012) The emerging role of ROS-generating NADPH oxidase NOX4 in DNA-damage responses. Mutat. Res. 751, 77-81
126. White, C. R., Brock, T. A., Chang, L. Y., Crapo, J., Briscoe, P., Ku, D., Bradley, W. A., Gianturco, S. H., Gore, J., Freeman, B. A. et al. (1994) Superoxide and peroxynitrite in atherosclerosis. Proc. Natl. Acad. Sci. U.S.A. 91, 1044-1048
127. Griendling, K. K., Sorescu, D., Lassegue, B. and Ushio-Fukai, M. (2000) Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler. Thromb. Vasc. Biol. 20, 2175-2183
128. Tabet, F., Savoia, C., Schiffrin, E. L. and Touyz, R. M. (2004) Differential calcium regulation by hydrogen peroxide and superoxide in vascular smooth muscle cells from spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 44, 200-208
129. Ushio-Fukai, M., Alexander, R. W., Akers, M. and Griendling, K. K. (1998) p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J. Biol. Chem. 273, 15022-15029
130. Millar, T. M., Phan, V. and Tibbles, L. A. (2007) ROS generation in endothelial hypoxia and reoxygenation stimulates MAP kinase signaling and kinase-dependent neutrophil recruitment. Free Radical Biol. Med. 42, 1165-1177
131. Forstermann, U. (2008) Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nat. Clin. Pract. Cardiovasc. Med. 5, 338-349
132. Bedard, K., Lardy, B. and Krause, K. H. (2007) NOX family NADPH oxidases: not just in mammals. Biochimie 89, 1107-1112
133. Sorce, S., Krause, K. H. and Jaquet, V. (2012) Targeting NOX enzymes in the central nervous system: therapeutic opportunities. Cell. Mol. Life Sci. 69, 2387-2407
134. Takac, I., Schroder, K. and Brandes, R. P. (2011) The Nox family of NADPH oxidases: friend or foe of the vascular system Curr. Hypertens. Rep. 14, 70-78
135. Arden, G. B. and Sivaprasad, S. (2011) Hypoxia and oxidative stress in the causation of diabetic retinopathy. Curr. Diabetes Rev. 7, 291-304
136. Futterman, S. (1975) Metabolism and photochemistry in the retina. In Physiology of the Eye, 6th Edition (Moses, R. A., ed.), pp. 406-419, Mosby, St Louis
137. Papp, A., Nemeth, I., Karg, E. and Papp, E. (1999) Glutathione status in retinopathy of prematurity. Free Radical Biol. Med. 27, 738-743
138. Chen, W., Hunt, D. M., Lu, H. and Hunt, R. C. (1999) Expression of antioxidant protective proteins in the rat retina during prenatal and postnatal development. Invest. Ophthalmol. Visual Sci. 40, 744-751
139. Parad, R. B., Allred, E. N., Rosenfeld, W. N. and Davis, J. M. (2012) Reduction of retinopathy of prematurity in extremely low gestational age newborns treated with recombinant human cu/zn superoxide dismutase. Neonatology 102, 139-144
140. Brooks, S. E., Gu, X., Samuel, S., Marcus, D. M., Bartoli, M., Huang, P. L. and Caldwell, R. B. (2001) Reduced severity of oxygen-induced retinopathy in eNOS-deficient mice. Invest. Ophthalmol. Visual Sci. 42, 222-228
141. Beauchamp, M. H., Sennlaub, F., Speranza, G., Gobeil, Jr, F., Checchin, D., Kermorvant-Duchemin, E., Abran, D., Hardy, P., Lachapelle, P., Varma, D. R. and Chemtob, S. (2004) Redox-dependent effects of nitric oxide on microvascular integrity in oxygen-induced retinopathy. Free Radical Biol. Med. 37, 1885-1894
142. Gu, X., El-Remessy, A. B., Brooks, S. E., Al-Shabrawey, M., Tsai, N. T. and Caldwell, R. B. (2003) Hyperoxia induces retinal vascular endothelial cell apoptosis through formation of peroxynitrite. Am. J. Physiol. Cell Physiol. 285, C546-C554
143. Niesman, M. R., Johnson, K. A. and Penn, J. S. (1997) Therapeutic effect of liposomal superoxide dismutase in an animal model of retinopathy of prematurity. Neurochem. Res. 22, 597-605
144. Abdelsaid, M. A., Pillai, B. A., Matragoon, S., Prakash, R., Al-Shabrawey, M. and El-Remessy, A. B. (2010) Early intervention of tyrosine nitration prevents vaso-obliteration and neovascularization in ischemic retinopathy. J. Pharmacol. Exp. Ther. 332, 125-134
145. Giacco, F. and Brownlee, M. (2010) Oxidative stress and diabetic complications. Circ. Res. 107, 1058-1070
146. Berner, A. K., Brouwers, O., Pringle, R., Klaassen, I., Colhoun, L., McVicar, C., Brockbank, S., Curry, J. W., Miyata, T., Brownlee, M. et al. (2011) Protection against methylglyoxal-derived AGEs by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology. Diabetologia 55, 845-854
147. Yatoh, S., Mizutani, M., Yokoo, T., Kozawa, T., Sone, H., Toyoshima, H., Suzuki, S., Shimano, H., Kawakami, Y., Okuda, Y. and Yamada, N. (2006) Antioxidants and an inhibitor of advanced glycation ameliorate death of retinal microvascular cells in diabetic retinopathy. Diabetes Metab. Res. Rev. 22, 38-45
148. Coso, S., Harrison, I., Harrison, C. B., Vinh, A., Sobey, C. G., Drummond, G. R., Williams, E. D. and Selemidis, S. (2012) NADPH oxidases as regulators of tumor angiogenesis: current and emerging concepts. Antioxid. Redox Signaling 16, 1229-1247
149. Banfi, B., Tirone, F., Durussel, I., Knisz, J., Moskwa, P., Molnar, G. Z., Krause, K. H. and Cox, J. A. (2004) Mechanism of Ca2+ activation of the NADPH oxidase 5 (NOX5) J. Biol. Chem. 279, 18583-18591
150. Takac, I., Schroder, K., Zhang, L., Lardy, B., Anilkumar, N., Lambeth, J. D., Shah, A. M., Morel, F. and Brandes, R. P. (2011) The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4. J. Biol. Chem. 286, 13304-13313
151. Ago, T., Kuroda, J., Kamouchi, M., Sadoshima, J. and Kitazono, T. (2011) Pathophysiological roles of NADPH oxidase/nox family proteins in the vascular system. Review and perspective. Circ. J. 75, 1791-1800
152. Arjamaa, O. and Nikinmaa, M. (2006) Oxygen-dependent diseases in the retina: role of hypoxia-inducible factors. Exp. Eye Res. 83, 473-483
153. Duan, L. J., Takeda, K. and Fong, G. H. (2011) Prolyl hydroxylase domain protein 2 (PHD2) mediates oxygen-induced retinopathy in neonatal mice. Am. J. Pathol. 178, 1881-1890
154. Huang, H., Van de Veire, S., Dalal, M., Parlier, R., Semba, R. D., Carmeliet, P. and Vinores, S. A. (2011) Reduced retinal neovascularization, vascular permeability and apoptosis in ischemic retinopathy in the absence of prolyl hydroxylase-1 due to the prevention of hyperoxia-induced vascular obliteration. Invest. Ophthalmol. Visual Sci. 52, 7565-7573
155. Sears, J. E., Hoppe, G., Ebrahem, Q. and Anand-Apte, B. (2008) Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy. Proc. Natl. Acad. Sci. U.S.A. 105, 19898-19903
156. Arany, Z., Foo, S. Y., Ma, Y., Ruas, J. L., Bommi-Reddy, A., Girnun, G., Cooper, M., Laznik, D., Chinsomboon, J., Rangwala, S. M. et al. (2008) HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1α. Nature 451, 1008-1012
157. Kietzmann, T. and Gorlach, A. (2005) Reactive oxygen species in the control of hypoxia-inducible factor-mediated gene expression. Semin. Cell. Dev. Biol. 16, 474-486
158. Brunelle, J. K., Bell, E. L., Quesada, N. M., Vercauteren, K., Tiranti, V., Zeviani, M., Scarpulla, R. C. and Chandel, N. S. (2005) Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab. 1, 409-414
159. Schafer, M., Schafer, C., Ewald, N., Piper, H. M. and Noll, T. (2003) Role of redox signaling in the autonomous proliferative response of endothelial cells to hypoxia. Circ. Res. 92, 1010-1015
160. Mollen, K. P., McCloskey, C. A., Tanaka, H., Prince, J. M., Levy, R. M., Zuckerbraun, B. S. and Billiar, T. R. (2007) Hypoxia activates c-Jun N-terminal kinase via Rac1-dependent reactive oxygen species production in hepatocytes. Shock 28, 270-277
161. Goyal, P., Weissmann, N., Grimminger, F., Hegel, C., Bader, L., Rose, F., Fink, L., Ghofrani, H. A., Schermuly, R. T., Schmidt, H. H., Seeger, W. and Hanze, J. (2004) Upregulation of NAD(P)H oxidase 1 in hypoxia activates hypoxia-inducible factor 1 via increase in reactive oxygen species. Free Radical Biol. Med. 36, 1279-1288
162. Malec, V., Gottschald, O. R., Li, S., Rose, F., Seeger, W. and Hanze, J. (2010) HIF-1 α signaling is augmented during intermittent hypoxia by induction of the Nrf2 pathway in NOX1-expressing adenocarcinoma A549 cells. Free Radical Biol. Med. 48, 1626-1635
163. Brewer, A. C., Murray, T. V., Arno, M., Zhang, M., Anilkumar, N. P., Mann, G. E. and Shah, A. M. (2011) Nox4 regulates Nrf2 and glutathione redox in cardiomyocytes in vivo. Free Radical Biol. Med. 51, 205-215
164. Maranchie, J. K. and Zhan, Y. (2005) Nox4 is critical for hypoxia-inducible factor 2α transcriptional activity in von Hippel-Lindau-deficient renal cell carcinoma. Cancer Res. 65, 9190-9193
165. Diebold, I., Flugel, D., Becht, S., Belaiba, R. S., Bonello, S., Hess, J., Kietzmann, T. and Gorlach, A. (2010) The hypoxia-inducible factor-2α is stabilized by oxidative stress involving NOX4. Antioxid. Redox Signaling 13, 425-436
166. Diebold, I., Petry, A., Hess, J. and Gorlach, A. (2010) The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1. Mol. Biol. Cell 21, 2087-2096
167. Brueckl, C., Kaestle, S., Kerem, A., Habazettl, H., Krombach, F., Kuppe, H. and Kuebler, W. M. (2006) Hyperoxia-induced reactive oxygen species formation in pulmonary capillary endothelial cells in situ. Am. J. Respir. Cell Mol. Biol. 34, 453-463
168. Chowdhury, A. K., Watkins, T., Parinandi, N. L., Saatian, B., Kleinberg, M. E., Usatyuk, P. V. and Natarajan, V. (2005) Src-mediated tyrosine phosphorylation of p47phox in hyperoxia-induced activation of NADPH oxidase and generation of reactive oxygen species in lung endothelial cells. J. Biol. Chem. 280, 20700-20711
169. Parinandi, N. L., Kleinberg, M. A., Usatyuk, P. V., Cummings, R. J., Pennathur, A., Cardounel, A. J., Zweier, J. L., Garcia, J. G. and Natarajan, V. (2003) Hyperoxia-induced NAD(P)H oxidase activation and regulation by MAP kinases in human lung endothelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 284, L26-L38
170. Calvani, M., Comito, G., Giannoni, E. and Chiarugi, P. (2012) Time-dependent stabilization of hypoxia inducible factor-1α by different intracellular sources of reactive oxygen species. PLoS ONE 7, e38388
171. Ushio-Fukai, M. (2007) VEGF signaling through NADPH oxidase-derived ROS. Antioxid. Redox Signaling 9, 731-739
172. Papa, S., Zazzeroni, F., Pham, C. G., Bubici, C. and Franzoso, G. (2004) Linking JNK signaling to NF-κB: a key to survival. J. Cell. Sci. 117, 5197-5208
173. Gorlach, A. and Bonello, S. (2008) The cross-talk between NF-κB and HIF-1: further evidence for a significant liaison. Biochem. J. 412, e17-e19
174. Walmsley, S. R., Print, C., Farahi, N., Peyssonnaux, C., Johnson, R. S., Cramer, T., Sobolewski, A., Condliffe, A. M., Cowburn, A. S., Johnson, N. and Chilvers, E. R. (2005) Hypoxia-induced neutrophil survival is mediated by HIF-1α-dependent NF-κB activity. J. Exp. Med. 201, 105-115
175. Batra, S., Balamayooran, G. and Sahoo, M. K. (2011) Nuclear factor-κB: a key regulator in health and disease of lungs. Arch. Immunol. Ther. Exp. 59, 335-351
176. Sato, T., Kusaka, S., Shimojo, H. and Fujikado, T. (2009) Simultaneous analyses of vitreous levels of 27 cytokines in eyes with retinopathy of prematurity. Ophthalmology 116, 2165-2169
177. Oh, I. K., Kim, S. W., Oh, J., Lee, T. S. and Huh, K. (2010) Inflammatory and angiogenic factors in the aqueous humor and the relationship to diabetic retinopathy. Curr. Eye Res. 35, 1116-1127
178. Davies, M. H., Eubanks, J. P. and Powers, M. R. (2006) Microglia and macrophages are increased in response to ischemia-induced retinopathy in the mouse retina. Mol. Vision 12, 467-477
179. Kayakabe, K., Kuroiwa, T., Sakurai, N., Ikeuchi, H., Kadiombo, A. T., Sakairi, T., Matsumoto, T., Maeshima, A., Hiromura, K. and Nojima, Y. (2012) Interleukin-6 promotes destabilized angiogenesis by modulating angiopoietin expression in rheumatoid arthritis. Rheumatology 51, 1571-1579
180. Kyriakakis, E., Cavallari, M., Pfaff, D., Fabbro, D., Mestan, J., Philippova, M., De Libero, G., Erne, P. and Resink, T. J. (2011) IL-8-mediated angiogenic responses of endothelial cells to lipid antigen activation of iNKT cells depend on EGFR transactivation. J. Leukocyte Biol. 90, 929-939
181. Lee, J. M., Song, J. Y., Baek, M., Jung, H. Y., Kang, H., Han, I. B., Kwon, Y. D. and Shin, D. E. (2011) Interleukin-1β induces angiogenesis and innervation in human intervertebral disc degeneration. J. Orthop. Res. 29, 265-269
182. Dvoriantchikova, G., Barakat, D., Brambilla, R., Agudelo, C., Hernandez, E., Bethea, J. R., Shestopalov, V. I. and Ivanov, D. (2009) Inactivation of astroglial NF-κ B promotes survival of retinal neurons following ischemic injury. Eur J. Neurosci. 30, 175-185
183. Barakat, D. J., Dvoriantchikova, G., Ivanov, D. and Shestopalov, V. I. (2012) Astroglial NF-κB mediates oxidative stress by regulation of NADPH oxidase in a model of retinal ischemia reperfusion injury. J. Neurochem. 120, 586-597
184. Diebold, I., Djordjevic, T., Petry, A., Hatzelmann, A., Tenor, H., Hess, J. and Gorlach, A. (2009) Phosphodiesterase 2 mediates redox-sensitive endothelial cell proliferation and angiogenesis by thrombin via Rac1 and NADPH oxidase 2. Circ. Res. 104, 1169-1177
185. Urao, N., Inomata, H., Razvi, M., Kim, H. W., Wary, K., McKinney, R., Fukai, T. and Ushio-Fukai, M. (2008) Role of nox2-based NADPH oxidase in bone marrow and progenitor cell function involved in neovascularization induced by hindlimb ischemia. Circ. Res. 103, 212-220
186. Zhang, M., Brewer, A. C., Schroder, K., Santos, C. X., Grieve, D. J., Wang, M., Anilkumar, N., Yu, B., Dong, X., Walker, S. J. et al. (2010) NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 107, 18121-18126
187. Al-Shabrawey, M., Bartoli, M., El-Remessy, A. B., Platt, D. H., Matragoon, S., Behzadian, M. A., Caldwell, R. W. and Caldwell, R. B. (2005) Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy. Am. J. Pathol. 167, 599-607
188. Selemidis, S., Sobey, C. G., Wingler, K., Schmidt, H. H. and Drummond, G. R. (2008) NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition. Pharmacol. Ther. 120, 254-291
189. Adamis, A. P. and Berman, A. J. (2008) Immunological mechanisms in the pathogenesis of diabetic retinopathy. Sem. Immunopathol. 30, 65-84
190. Sivakumar, V., Foulds, W. S., Luu, C. D., Ling, E. A. and Kaur, C. (2011) Retinal ganglion cell death is induced by microglia derived pro-inflammatory cytokines in the hypoxic neonatal retina. J. Pathol. 224, 245-260
191. Ibrahim, A. S., El-Remessy, A. B., Matragoon, S., Zhang, W., Patel, Y., Khan, S., Al-Gayyar, M. M., El-Shishtawy, M. M. and Liou, G. I. (2011) Retinal microglial activation and inflammation induced by amadori-glycated albumin in a rat model of diabetes. Diabetes 60, 1122-1133
192. Wang, A. L., Yu, A. C., He, Q. H., Zhu, X. and Tso, M. O. (2007) AGEs mediated expression and secretion of TNF α in rat retinal microglia. Exp. Eye Res. 84, 905-913
193. Saito, Y., Geisen, P., Uppal, A. and Hartnett, M. E. (2007) Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity. Mol. Vision 13, 840-853
194. Saito, Y., Uppal, A., Byfield, G., Budd, S. and Hartnett, M. E. (2008) Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model. Invest. Ophthalmol. Visual Sci. 49, 1591-1598
195. Byfield, G., Budd, S. and Hartnett, M. E. (2009) The role of supplemental oxygen and JAK/STAT signaling in intravitreous neovascularization in a ROP rat model. Invest. Ophthalmol. Visual Sci. 50, 3360-3365
196. 2 - and systolic blood pressure in mice. Circ. Res. 89, 408-414
197. Tawfik, A., Sanders, T., Kahook, K., Akeel, S., Elmarakby, A. and Al-Shabrawey, M. (2009) Suppression of retinal peroxisome proliferator-activated receptor γ in experimental diabetes and oxygen-induced retinopathy: role of NADPH oxidase. Invest. Ophthalmol. Visual Sci. 50, 878-884
198. Muranaka, K., Yanagi, Y., Tamaki, Y., Usui, T., Kubota, N., Iriyama, A., Terauchi, Y., Kadowaki, T. and Araie, M. (2006) Effects of peroxisome proliferator-activated receptor γ and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model. Invest. Ophthalmol. Visual Sci. 47, 4547-4552
199. Mustapha, N. M., Tarr, J. M., Kohner, E. M. and Chibber, R. (2010) NADPH oxidase versus mitochondria-derived ROS in glucose-induced apoptosis of pericytes in early diabetic retinopathy. J. Ophthalmol. 2010, 746978
200. Al-Shabrawey, M., Rojas, M., Sanders, T., Behzadian, A., El-Remessy, A., Bartoli, M., Parpia, A. K., Liou, G. and Caldwell, R. B. (2008) Role of NADPH oxidase in retinal vascular inflammation. Invest. Ophthalmol. Visual Sci. 49, 3239-3244
201. Al-Shabrawey, M., Bartoli, M., El-Remessy, A. B., Ma, G., Matragoon, S., Lemtalsi, T., Caldwell, R. W. and Caldwell, R. B. (2008) Role of NADPH oxidase and Stat3 in statin-mediated protection against diabetic retinopathy. Invest. Ophthalmol. Visual Sci. 49, 3231-3238
202. Jarajapu, Y. P., Caballero, S., Verma, A., Nakagawa, T., Lo, M. C., Li, Q. and Grant, M. B. (2011) Blockade of NADPH oxidase restores vasoreparative function in diabetic CD34+ cells. Invest. Ophthalmol. Visual Sci. 52, 5093-5104
203. Brownlee, M. (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414, 813-820
204. Li, L. and Renier, G. (2006) Activation of nicotinamide adenine dinucleotide phosphate (reduced form) oxidase by advanced glycation end products links oxidative stress to altered retinal vascular endothelial growth factor expression. Metab., Clin. Exp. 55, 1516-1523
205. Simo, R., Carrasco, E., Garcia-Ramirez, M. and Hernandez, C. (2006) Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy. Curr. Diabetes Rev. 2, 71-98
206. Yamagishi, S., Nakamura, K., Matsui, T., Inagaki, Y., Takenaka, K., Jinnouchi, Y., Yoshida, Y., Matsuura, T., Narama, I., Motomiya, Y. et al. (2006) Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression. J. Biol. Chem. 281, 20213-20220
207. Sheikpranbabu, S., Haribalaganesh, R., Lee, K. J. and Gurunathan, S. (2010) Pigment epithelium-derived factor inhibits advanced glycation end products-induced retinal vascular permeability. Biochimie 92, 1040-1051
208. Kim, J., Kim, K. M., Kim, C. S., Sohn, E., Lee, Y. M., Jo, K. and Kim, J. S. (2012) Puerarin inhibits the retinal pericyte apoptosis induced by advanced glycation end products in vitro and in vivo by inhibiting NADPH oxidase-related oxidative stress. Free Radical Biol. Med. 53, 357-365
209. Li, J., Wang, J. J., Yu, Q., Chen, K., Mahadev, K. and Zhang, S. X. (2010) Inhibition of reactive oxygen species by Lovastatin downregulates vascular endothelial growth factor expression and ameliorates blood-retinal barrier breakdown in db/db mice: role of NADPH oxidase 4. Diabetes 59, 1528-1538
210. Ago, T., Kitazono, T., Kuroda, J., Kumai, Y., Kamouchi, M., Ooboshi, H., Wakisaka, M., Kawahara, T., Rokutan, K., Ibayashi, S. and Iida, M. (2005) NAD(P)H oxidases in rat basilar arterial endothelial cells. Stroke 36, 1040-1046
211. Sorescu, G. P., Song, H., Tressel, S. L., Hwang, J., Dikalov, S., Smith, D. A., Boyd, N. L., Platt, M. O., Lassegue, B., Griendling, K. K. and Jo, H. (2004) Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress induces monocyte adhesion by stimulating reactive oxygen species production from a nox1-based NADPH oxidase. Circ. Res. 95, 773-779
212. Higashi, M., Shimokawa, H., Hattori, T., Hiroki, J., Mukai, Y., Morikawa, K., Ichiki, T., Takahashi, S. and Takeshita, A. (2003) Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system. Circ. Res. 93, 767-775
213. Van Buul, J. D., Fernandez-Borja, M., Anthony, E. C. and Hordijk, P. L. (2005) Expression and localization of NOX2 and NOX4 in primary human endothelial cells. Antioxid. Redox Signaling 7, 308-317
214. BelAiba, R. S., Djordjevic, T., Petry, A., Diemer, K., Bonello, S., Banfi, B., Hess, J., Pogrebniak, A., Bickel, C. and Gorlach, A. (2007) NOX5 variants are functionally active in endothelial cells. Free Radical Biol. Med. 42, 446-459
215. Manea, A., Raicu, M. and Simionescu, M. (2005) Expression of functionally phagocyte-type NAD(P)H oxidase in pericytes: effect of angiotensin II and high glucose. Biol. Cell 97, 723-734
216. Dvoriantchikova, G., Grant, J., Santos, A. R., Hernandez, E. and Ivanov, D. (2012) Neuronal NAD(P)H oxidases contribute to ROS production and mediate RGC death after ischemia. Invest. Ophthalmol. Visual Sci. 53, 2823-2830
217. Wang, J., Xu, X., Elliott, M. H., Zhu, M. and Le, Y. Z. (2010) Muller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage. Diabetes 59, 2297-2305
218. Hammes, H. P., Lin, J., Bretzel, R. G., Brownlee, M. and Breier, G. (1998) Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat. Diabetes 47, 401-406
219. Yokota, H., Narayanan, S. P., Zhang, W., Liu, H., Rojas, M., Xu, Z., Lemtalsi, T., Nagaoka, T., Yoshida, A., Brooks, S. E. et al. (2011) Neuroprotection from retinal ischemia/reperfusion injury by NOX2 NADPH oxidase deletion. Invest. Ophthalmol. Visual Sci. 52, 8123-8131
220. Hwang, J., Saha, A., Boo, Y. C., Sorescu, G. P., McNally, J. S., Holland, S. M., Dikalov, S., Giddens, D. P., Griendling, K. K., Harrison, D. G. and Jo, H. (2003) Oscillatory shear stress stimulates endothelial production of O2 - from p47phox-dependent NAD(P)H oxidases, leading to monocyte adhesion. J. Biol. Chem. 278, 47291-47298
221. Grote, K., Flach, I., Luchtefeld, M., Akin, E., Holland, S. M., Drexler, H. and Schieffer, B. (2003) Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidase-derived reactive oxygen species. Circ. Res. 92, e80-86
222. Suzuma, I., Murakami, T., Suzuma, K., Kaneto, H., Watanabe, D., Ojima, T., Honda, Y., Takagi, H. and Yoshimura, N. (2007) Cyclic stretch-induced reactive oxygen species generation enhances apoptosis in retinal pericytes through c-jun NH2-terminal kinase activation. Hypertension 49, 347-354
223. Kamizato, M., Nishida, K., Masuda, K., Takeo, K., Yamamoto, Y., Kawai, T., Teshima-Kondo, S., Tanahashi, T. and Rokutan, K. (2009) Interleukin 10 inhibits interferon γ - and tumor necrosis factor α-stimulated activation of NADPH oxidase 1 in human colonic epithelial cells and the mouse colon. J. Gastroenterol. 44, 1172-1184
224. Kuwano, Y., Tominaga, K., Kawahara, T., Sasaki, H., Takeo, K., Nishida, K., Masuda, K., Kawai, T., Teshima-Kondo, S. and Rokutan, K. (2008) Tumor necrosis factor α activates transcription of the NADPH oxidase organizer 1 (NOXO1) gene and upregulates superoxide production in colon epithelial cells. Free Radical Biol. Med. 45, 1642-1652
225. St Hilaire, C., Koupenova, M., Carroll, S. H., Smith, B. D. and Ravid, K. (2008) TNF-α upregulates the A2B adenosine receptor gene: the role of NAD(P)H oxidase 4. Biochem. Biophys. Res. Commun. 375, 292-296
226. Park, H. S., Jung, H. Y., Park, E. Y., Kim, J., Lee, W. J. and Bae, Y. S. (2004) Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-κB. J. Immunol. 173, 3589-3593
227. Kawahara, T., Kohjima, M., Kuwano, Y., Mino, H., Teshima-Kondo, S., Takeya, R., Tsunawaki, S., Wada, A., Sumimoto, H. and Rokutan, K. (2005) Helicobacter pylori lipopolysaccharide activates Rac1 and transcription of NADPH oxidase Nox1 and its organizer NOXO1 in guinea pig gastric mucosal cells. Am. J. Physiol. Cell Physiol. 288, C450-C457
228. Massey, K. J., Hong, N. J. and Garvin, J. L. (2012) Angiotensin II stimulates superoxide production in the thick ascending limb by activiating NOX4. Am. J. Physiol. Cell Physiol. 303, C781-C791
229. Dikalov, S. I., Dikalova, A. E., Bikineyeva, A. T., Schmidt, H. H., Harrison, D. G. and Griendling, K. K. (2008) Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production. Free Radical Biol. Med. 45, 1340-1351
230. Wingler, K., Wunsch, S., Kreutz, R., Rothermund, L., Paul, M. and Schmidt, H. H. (2001) Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo. Free Radical Biol. Med. 31, 1456-1464
231. Lassegue, B., Sorescu, D., Szocs, K., Yin, Q., Akers, M., Zhang, Y., Grant, S. L., Lambeth, J. D. and Griendling, K. K. (2001) Novel gp91phox homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ. Res. 88, 888-894
232. Briones, A. M., Tabet, F., Callera, G. E., Montezano, A. C., Yogi, A., He, Y., Quinn, M. T., Salaices, M. and Touyz, R. M. (2011) Differential regulation of Nox1, Nox2 and Nox4 in vascular smooth muscle cells from WKY and SHR. J. Am. Soc. Hypertens. 5, 137-153
233. Thakur, S., Du, J., Hourani, S., Ledent, C. and Li, J. M. (2010) Inactivation of adenosine A2A receptor attenuates basal and angiotensin II-induced ROS production by Nox2 in endothelial cells. J. Biol. Chem. 285, 40104-40113
234. Fu, Y., Zhang, R., Lu, D., Liu, H., Chandrashekar, K., Juncos, L. A. and Liu, R. (2010) NOX2 is the primary source of angiotensin II-induced superoxide in the macula densa. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298, R707-R712
235. Montezano, A. C., Burger, D., Paravicini, T. M., Chignalia, A. Z., Yusuf, H., Almasri, M., He, Y., Callera, G. E., He, G., Krause, K. H., Lambeth, D., Quinn, M. T. and Touyz, R. M. (2010) Nicotinamide adenine dinucleotide phosphate reduced oxidase (Nox5) regulation by angiotensin II and endothelin-1 is mediated via calcium/calmodulin-dependent, rac-1-independent pathways in human endothelial cells. Circ. Res. 106, 1363-1373
236. Montezano, A. C. and Touyz, R. M. (2012) Oxidative stress, Noxs and hypertension: experimental evidence and clinical controversies. Ann Med. 44 (Suppl. 1), S2-S16
237. Wei, H., Mi, X., Ji, L., Yang, L., Xia, Q., Wei, Y., Miyamori, I. and Fan, C. (2010) Protein kinase C-δ is involved in induction of NOX1 gene expression by aldosterone in rat vascular smooth muscle cells. Biochemistry (Moscow) 75, 304-309
238. Nakamura, T., Kataoka, K., Fukuda, M., Nako, H., Tokutomi, Y., Dong, Y. F., Ichijo, H., Ogawa, H. and Kim-Mitsuyama, S. (2009) Critical role of apoptosis signal-regulating kinase 1 in aldosterone/salt-induced cardiac inflammation and fibrosis. Hypertension 54, 544-551
239. Nishiyama, A., Yao, L., Nagai, Y., Miyata, K., Yoshizumi, M., Kagami, S., Kondo, S., Kiyomoto, H., Shokoji, T., Kimura, S. et al. (2004) Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats. Hypertension 43, 841-848
240. Zhu, X., Manning, Jr, R. D., Lu, D., Gomez-Sanchez, C. E., Fu, Y., Juncos, L. A. and Liu, R. (2011) Aldosterone stimulates superoxide production in macula densa cells. Am. J. Physiol. Renal Physiol. 301, F529-F535
241. Stas, S., Whaley-Connell, A., Habibi, J., Appesh, L., Hayden, M. R., Karuparthi, P. R., Qazi, M., Morris, E. M., Cooper, S. A., Link, C. D. et al. (2007) Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling. Endocrinology. 148, 3773-3780
242. Johar, S., Cave, A. C., Narayanapanicker, A., Grieve, D. J. and Shah, A. M. (2006) Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase. FASEB J. 20, 1546-1548
243. Bayorh, M. A., Rollins-Hairston, A., Adiyiah, J., Lyn, D. and Eatman, D. (2011) Eplerenone suppresses aldosterone/ salt-induced expression of NOX-4. JRAAS 12, 195-201
244. Downie, L. E., Vessey, K., Miller, A., Ward, M. M., Pianta, M. J., Vingrys, A. J., Wilkinson-Berka, J. L. and Fletcher, E. L. (2009) Neuronal and glial cell expression of angiotensin II type 1 (AT1) and type 2 (AT2) receptors in the rat retina. Neuroscience 161, 195-213
245. Downie, L. E., Pianta, M. J., Vingrys, A. J., Wilkinson-Berka, J. L. and Fletcher, E. L. (2008) AT1 receptor inhibition prevents astrocyte degeneration and restores vascular growth in oxygen-induced retinopathy. Glia 56, 1076-1090
246. Wilkinson-Berka, J. L., Tan, G., Binger, K. J., Sutton, L., McMaster, K., Deliyanti, D., Perera, G., Campbell, D. J. and Miller, A. G. (2011) Aliskiren reduces vascular pathology in diabetic retinopathy and oxygen-induced retinopathy in the transgenic (mRen-2)27 rat. Diabetologia 54, 2724-2735
247. Phipps, J. A., Wilkinson-Berka, J. L. and Fletcher, E. L. (2007) Retinal dysfunction in diabetic ren-2 rats is ameliorated by treatment with valsartan but not atenolol. Invest. Ophthalmol. Visual Sci. 48, 927-934
248. Moravski, C. J., Skinner, S. L., Stubbs, A. J., Sarlos, S., Kelly, D. J., Cooper, M. E., Gilbert, R. E. and Wilkinson-Berka, J. L. (2003) The renin-angiotensin system influences ocular endothelial cell proliferation in diabetes: transgenic and interventional studies. Am. J. Pathol. 162, 151-160
249. Mauer, M., Zinman, B., Gardiner, R., Suissa, S., Sinaiko, A., Strand, T., Drummond, K., Donnelly, S., Goodyer, P., Gubler, M. C. and Klein, R. (2009) Renal and retinal effects of enalapril and losartan in type 1 diabetes. N. Engl. J. Med. 361, 40-51
250. Chaturvedi, N., Sjolie, A. K., Stephenson, J. M., Abrahamian, H., Keipes, M., Castellarin, A., Rogulja-Pepeonik, Z. and Fuller, J. H. (1998) Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. Lancet 351, 28-31
251. Chaturvedi, N., Porta, M., Klein, R., Orchard, T., Fuller, J., Parving, H. H., Bilous, R. and Sjolie, A. K. (2008) Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials. Lancet 372, 1394-1402
252. Sjolie, A. K., Klein, R., Porta, M., Orchard, T., Fuller, J., Parving, H. H., Bilous, R., Aldington, S. and Chaturvedi, N. (2011) Retinal microaneurysm count predicts progression and regression of diabetic retinopathy. Post-hoc results from the DIRECT Programme. Diabetic Med. 28, 345-351
253. Sjolie, A. K., Klein, R., Porta, M., Orchard, T., Fuller, J., Parving, H. H., Bilous, R. and Chaturvedi, N. (2008) Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial. Lancet. 372, 1385-1393
254. Wilkinson-Berka, J. L., Tan, G., Jaworski, K. and Miller, A. G. (2009) Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology. Circ. Res. 104, 124-133
255. Zhao, M., Celerier, I., Bousquet, E., Jeanny, J. C., Jonet, L., Savoldelli, M., Offret, O., Curan, A., Farman, N., Jaisser, F. and Behar-Cohen, F. (2012) Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy. J. Clin. Invest. 122, 2672-2679
256. Berka, J. L., Stubbs, A. J., Wang, D. Z., DiNicolantonio, R., Alcorn, D., Campbell, D. J. and Skinner, S. L. (1995) Renin-containing Muller cells of the retina display endocrine features. Invest. Ophthalmol. Visual Sci. 36, 1450-1458
257. Sarlos, S. and Wilkinson-Berka, J. L. (2005) The renin-angiotensin system and the developing retinal vasculature. Invest. Ophthalmol. Visual Sci. 46, 1069-1077
258. Rojas, M., Zhang, W., Lee, D. L., Romero, M. J., Nguyen, D. T., Al-Shabrawey, M., Tsai, N. T., Liou, G. I., Brands, M. W., Caldwell, R. W. and Caldwell, R. B. (2009) Role of IL-6 in angiotensin II-induced retinal vascular inflammation. Invest. Ophthalmol. Visual Sci. 51, 1709-1718
259. Fukumoto, M., Takai, S., Ishizaki, E., Sugiyama, T., Oku, H., Jin, D., Sakaguchi, M., Sakonjo, H., Ikeda, T. and Miyazaki, M. (2008) Involvement of angiotensin II-dependent vascular endothelial growth factor gene expression via NADPH oxidase in the retina in a type 2 diabetic rat model. Curr. Eye Res. 33, 885-891
260. Chen, P., Guo, A. M., Edwards, P. A., Trick, G. and Scicli, A. G. (2007) Role of NADPH oxidase and ANG II in diabetes-induced retinal leukostasis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293, R1619-R1629
261. Fujita, T., Hirooka, K., Nakamura, T., Itano, T., Nishiyama, A., Nagai, Y. and Shiraga, F. (2012) Neuroprotective effects of angiotensin II type 1 receptor (AT1-R) blocker via modulating AT1-R signaling and decreased extracellular glutamate levels. Invest. Ophthalmol. Visual Sci. 53, 4099-4110
262. Valente, A. J., Yoshida, T., Murthy, S. N., Sakamuri, S. S., Katsuyama, M., Clark, R. A., Delafontaine, P. and Chandrasekar, B. (2012) Angiotensin II enhances AT1-Nox1 binding and stimulates arterial smooth muscle cell migration and proliferation through AT1, Nox1 and interleukin-18. Am. J. Physiol. Heart Circ. Physiol. 303, H282-H296
263. Mollnau, H., Wendt, M., Szocs, K., Lassegue, B., Schulz, E., Oelze, M., Li, H., Bodenschatz, M., August, M., Kleschyov, A. L. et al. (2002) Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ. Res. 90, E58-E65
264. Zimmerman, M. C., Dunlay, R. P., Lazartigues, E., Zhang, Y., Sharma, R. V., Engelhardt, J. F. and Davisson, R. L. (2004) Requirement for Rac1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain. Circ. Res. 95, 532-539
265. Wang, G., Anrather, J., Glass, M. J., Tarsitano, M. J., Zhou, P., Frys, K. A., Pickel, V. M. and Iadecola, C. (2006) Nox2, Ca2+ and protein kinase C play a role in angiotensin II-induced free radical production in nucleus tractus solitarius. Hypertension 48, 482-489
266. Chan, S. H., Hsu, K. S., Huang, C. C., Wang, L. L., Ou, C. C. and Chan, J. Y. (2005) NADPH oxidase-derived superoxide anion mediates angiotensin II-induced pressor effect via activation of p38 mitogen-activated protein kinase in the rostral ventrolateral medulla. Circ. Res. 97, 772-780
267. Zimmerman, M. C., Sharma, R. V. and Davisson, R. L. (2005) Superoxide mediates angiotensin II-induced influx of extracellular calcium in neural cells. Hypertension 45, 717-723
268. Sun, C., Sellers, K. W., Sumners, C. and Raizada, M. K. (2005) NAD(P)H oxidase inhibition attenuates neuronal chronotropic actions of angiotensin II. Circ. Res. 96, 659-666
269. Cai, H., Griendling, K. K. and Harrison, D. G. (2003) The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol. Sci. 24, 471-478
270. Gavazzi, G., Banfi, B., Deffert, C., Fiette, L., Schappi, M., Herrmann, F. and Krause, K. H. (2006) Decreased blood pressure in NOX1-deficient mice. FEBS Lett. 580, 497-504
271. De Miguel, C., Guo, C., Lund, H., Feng, D. and Mattson, D. L. (2010) Infiltrating T lymphocytes in the kidney increase oxidative stress and participate in the development of hypertension and renal disease. Am. J. Physiol. Renal Physiol. 300, F734-F742
272. Kasal, D. A., Barhoumi, T., Li, M. W., Yamamoto, N., Zdanovich, E., Rehman, A., Neves, M. F., Laurant, P., Paradis, P. and Schiffrin, E. L. (2011) T regulatory lymphocytes prevent aldosterone-induced vascular injury. Hypertension 59, 324-330
273. Guzik, T. J., Hoch, N. E., Brown, K. A., McCann, L. A., Rahman, A., Dikalov, S., Goronzy, J., Weyand, C. and Harrison, D. G. (2007) Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J. Exp. Med. 204, 2449-2460
274. Sicard, P., Acar, N., Gregoire, S., Lauzier, B., Bron, A. M., Creuzot-Garcher, C., Bretillon, L., Vergely, C. and Rochette, L. (2007) Influence of rosuvastatin on the NAD(P)H oxidase activity in the retina and electroretinographic response of spontaneously hypertensive rats. Br. J. Pharmacol. 151, 979-986
275. Antonetti, D. A., Barber, A. J., Bronson, S. K., Freeman, W. M., Gardner, T. W., Jefferson, L. S., Kester, M., Kimball, S. R., Krady, J. K., LaNoue, K. F. et al. (2006) Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes 55, 2401-2411
276. Diebold, I., Petry, A., Sabrane, K., Djordjevic, T., Hess, J. and Gorlach, A. (2012) The HIF1 target gene NOX2 promotes angiogenesis through urotensin-II. J. Cell. Sci. 125, 956-964
277. Xia, C., Meng, Q., Liu, L. Z., Rojanasakul, Y., Wang, X. R. and Jiang, B. H. (2007) Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor. Cancer Res. 67, 10823-10830
278. Pendyala, S., Gorshkova, I. A., Usatyuk, P. V., He, D., Pennathur, A., Lambeth, J. D., Thannickal, V. J. and Natarajan, V. (2009) Role of Nox4 and Nox2 in hyperoxia-induced reactive oxygen species generation and migration of human lung endothelial cells. Antioxid. Redox Signaling 11, 747-764
279. Muzaffar, S., Jeremy, J. Y., Angelini, G. D. and Shukla, N. (2012) NADPH oxidase 4 mediates upregulation of type 4 phosphodiesterases in human endothelial cells. J. Cell. Physiol. 227, 1941-1950
280. Schroder, K., Schutz, S., Schloffel, I., Batz, S., Takac, I., Weissmann, N., Michaelis, U. R., Koyanagi, M. and Brandes, R. P. (2011) Hepatocyte growth factor induces a proangiogenic phenotype and mobilizes endothelial progenitor cells by activating Nox2. Antioxid. Redox Signaling 15, 915-923
281. Jiang, F., Zhang, G., Hashimoto, I., Kumar, B. S., Bortolotto, S., Morrison, W. A. and Dusting, G. J. (2008) Neovascularization in an arterio-venous loop-containing tissue engineering chamber: role of NADPH oxidase. J. Cell. Mol. Med. 12, 2062-2072
282. Haddad, P., Dussault, S., Groleau, J., Turgeon, J., Michaud, S. E., Menard, C., Perez, G., Maingrette, F. and Rivard, A. (2009) Nox2-containing NADPH oxidase deficiency confers protection from hindlimb ischemia in conditions of increased oxidative stress. Arterioscler. Thromb. Vasc. Biol. 29, 1522-1528